Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salvadora persica extract for blood sugar and lipid profile in type 2 diabetes
IRCT20210906052392N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Oct 2021
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of miswak extract in type 2 diabetes mellitus (T2DM) and dyslipidemia, sponsored by Isfahan University of Medical Sciences. Primary endpoints: Change in blood glucose control and Change in lipid profile. Started Oct 2021; status: completed.
02
Drugs
miswak extract
03
Conditions
type 2 diabetes mellitus (T2DM)dyslipidemia
Beyond the preview
Go deeper on IRCT20210906052392N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210906052392N1.